Cancer
Researchers from Humanitas University in Milan, Italy have conducted a prospective observational study to evaluate the safety of romosozumab in women with cancer and osteoporosis, who are at high risk of fractures. The study involved 131 patients, with 19% having a history of cancer. The results showed that romosozumab was
Cancer
Researchers from China have detailed a novel concept in cancer treatment, integrating two distinct immunotherapeutic modalities to overcome the limitations of current therapies. The approach, known as Dual Distinct Immunotherapy (DDI), strategically combines different treatments to achieve a synergistic effect. This review highlights the potential of DDI in enhancing therapeutic
Cancer
Investigators at the University of California have published a new report on biotechnology and cancer gene therapy, revealing a promising strategy for targeting cancers driven by herpesviruses. The research team has devised a cancer gene therapy vector using the adeno-associated virus (AAV), which capitalizes on the latency-associated nuclear antigen (LANA)
Cancer
Researchers at Guangzhou Medical University have uncovered a crucial regulator of hierarchical cellular transitions in hepatocellular carcinoma (HCC), highlighting a potential target for cancer therapy. By analyzing public datasets and in vitro and in vivo models, the team identified the FOXM1/CEBPB axis as a key driver of developmental heterogeneity
Cancer
The AI in oncology market is expected to experience a significant growth, estimated to reach USD 9.1 billion by 2035, as per a report by Research and Markets. The market is expected to grow from USD 2.4 billion in 2025, driven by the increasing demand for advanced cancer
Cancer
Researchers at Spaulding Rehabilitation Hospital and Massachusetts General Hospital have detailed their findings on cancer gene therapy at the 3rd International Electronic Conference on Biomedicines. Held online from May 12 to 15, 2025, by the journal Biomedicines MDPI, the conference aimed to showcase recent research in biomedicines, particularly in the
Cancer
Research from the Chinese Academy of Agricultural Science has made significant strides in the field of biotechnology, particularly in the development of cancer gene therapy. A new study published in the journal Drug Delivery highlights the latest advancements in nucleic acid-based antibody delivery platforms, which hold promise for creating more
Cancer
Researchers at the Aristotle University of Thessaloniki have shed light on the characteristics of hematological cancer stem cells (HCSCs), a subpopulation of cells within hematological cancers that enhance malignancy and render treatment more challenging. By examining the existing literature, the study aimed to identify potential targets for improving immunotherapy clinical
Cancer
Scientists at MuDanJiang Medical University have developed a groundbreaking cancer treatment using macrophage membrane-coated nanoparticles, which have shown exceptional efficacy in targeting and killing cancer cells. These nanoparticles, called MGLD (Macrophage membrane/gelatin/laponite/doxorubicin), were engineered to evade immune clearance and induce autophagy and immunogenic cell death (ICD) in
Cancer
Researchers at the University of Miami have published a review article in the journal Nanomedicine, highlighting the potential of magnetoelectric nanoparticles (MENPs) in cancer therapy. According to the study, MENPs, which generate electric fields in response to magnetic fields, can be used to target and destroy cancer cells without causing
Cancer
As I discovered eight years ago with my own CT scan, these medical imaging procedures can come with a hidden cost - the potential for cancer induction due to radiation exposure. A landmark study in JAMA Internal Medicine, published in 2023, has shed light on the alarming risks associated with
Cancer
New research conducted by a team from the Huazhong University of Science and Technology in Wuhan, People's Republic of China, has made a significant breakthrough in cancer gene therapy. The team's study, published in Oncogene, has identified complement component 1q subcomponent binding protein (C1QBP) as a
